Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

Torkki, Paulus; Leskelä, Riikka‐Leena; Linna, Miika; Mäklin, Suvi; Mecklin∥, Jukka–Pekka; Bono, Petri; Kataja, Vesa; Karjalainen, Sakari

doi:10.1080/0284186x.2018.1438656

Cited by 7 publications

(6 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Na Finlândia verificou-se que os tipos de neoplasias malignas que representaram os maiores custos para o país foram: mama, próstata, colorretal, pulmão e leucemia 24 . Aparentemente, os cânceres de mama, próstata, colorretal e pulmão também geram elevados custos para a Previdência Social brasileira, uma vez que aparecem entre as principais localizações de câncer que geram benefícios.…”

Section: Discussionunclassified

Benefícios acidentários e previdenciários concedidos a portadores de câncer no Brasil, 2008-2014

Sales-Fonseca

Otero

Koifman

et al. 2023

Ciênc. saúde coletiva

View full text Add to dashboard Cite

Resumo O objetivo deste artigo é descrever a distribuição do câncer entre os benefícios concedidos pelo Registro Geral da Previdência Social (RGPS), de 2008 a 2014, no Brasil. Estudo ecológico com dados cedidos pelo Instituto Nacional do Seguro Social (INSS). Determinou-se a proporção de benefícios acidentários (relacionados ao trabalho) e previdenciários (gerais) concedidos por câncer no Brasil, entre os benefícios concedidos por todas as causas e realizou-se uma análise espacial para avaliar a distribuição geográfica dessas proporções, tendo os estados brasileiros como unidade de análise. O câncer foi motivo de concessão de 533.438 benefícios (2,9% do total de benefícios concedidos por todas as causas), com predomínio do sexo feminino nos benefícios previdenciários (53,7%) e do sexo masculino nos benefícios acidentários (71,6%). As maiores proporções de benefícios previdenciários por câncer ocorreram nas regiões Norte e Centro-Oeste. Em 19 dos 26 estados brasileiros e no Distrito Federal não houve concessão de benefício acidentário por câncer. A análise das ocorrências de câncer que geraram concessões de benefícios do RGPS sugere uma desproporcionalidade da concessão de benefícios previdenciários em relação aos acidentários, principalmente nas regiões Norte, Nordeste e Sul do Brasil.

show abstract

Section: Discussionunclassified

Benefícios acidentários e previdenciários concedidos a portadores de câncer no Brasil, 2008-2014

Sales-Fonseca

Otero

Koifman

et al. 2023

Ciênc. saúde coletiva

View full text Add to dashboard Cite

show abstract

“…The types of malignant neoplasms that represented the highest costs for Finland were found to be breast, prostate, colorectal, lung, and leukemia 24 . Apparently, breast, prostate, colorectal and lung cancers also generate high costs for Brazilian social security, since they appear among the main cancer locations that generate benefits.…”

Section: Discussionmentioning

confidence: 99%

Accident and social security benefits granted to cancer patients in Brazil, 2008-2014

Sales-Fonseca

Otero

Koifman

et al. 2023

Ciênc. saúde coletiva

View full text Add to dashboard Cite

This article aims to describe the distribution of cancer among the benefits granted by the General Social Security Registry, from 2008 to 2014, in Brazil. Ecological study using data given by the National Social Security Institute. The proportion of accidental (work-related) and social security (general) benefits granted by cancer in Brazil was determined, among the benefits granted for all causes, and a spatial analysis was conducted to assess the geographical distribution of these proportions, with the states Brazilians as a unit of analysis. Cancer was the reason for granting 533,438 benefits (2.9% of the total benefits granted for all causes), with a predominance of females in social security benefits (53.7%) and males in accidental benefits (71.6 %). The highest proportions of social security benefits for cancer occurred in North and Midwest regions. In 19 of the 26 Brazilian states (including all states in the southern region) and in the Federal District, there was no granting of accident benefits for cancer. The analysis of the occurrences of cancer that generated benefit concessions suggests a disproportionality in granting of social security benefits in relation to accident workers, mainly in North, Northeast and South regions of Brazil.

show abstract

“…The population (national) level economic burden of cancer has already been estimated and predicted in many countries 4–13 . However, there are currently few comprehensive data available for China.…”

Section: Introductionmentioning

confidence: 99%

“…The population (national) level economic burden of cancer has already been estimated and predicted in many countries. 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 However, there are currently few comprehensive data available for China. Most of the previous studies focus only on the per‐person direct medical expenditure related with CRC diagnosis and treatment alone.…”

Section: Introductionmentioning

confidence: 99%

Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis

Wang,

Li,

Lei

et al. 2023

Cancer Medicine

View full text Add to dashboard Cite

BackgroundColorectal cancer (CRC) is one of the most common cancers worldwide. Comprehensive data on the economic burden of CRC at a population‐level is critical in informing policymaking, but such data are currently limited in China.MethodsFrom a societal perspective, the economic burden of CRC in 2019 was estimated, including direct medical and nonmedical expenditure, disability, and premature‐death‐related indirect expenditure. Data on disease burden was taken from the GBD 2019 and analyzed using a prevalence‐based approach. The per‐person direct expenditure and work loss days were from a multicenter study; the premature‐death‐related expenditure was estimated using a human capital approach. Projections were conducted in different simulated scenarios. All expenditure data were in Chinese Yuan (CNY) and discounted to 2019.ResultsIn 2019, the estimated overall economic burden of CRC in China was CNY170.5 billion (0.189% of the local GDP). The direct expenditure was CNY106.4 billion (62.4% of the total economic burden), 91.4% of which was a direct medical expenditure. The indirect expenditure was CNY64.1 billion, of which 63.7% was related to premature death. The predicted burden would reach CNY560.0 billion in 2030 given constant trends for disease burden; however, it would be alternatively reduced to <CNY515.2 billion if the cancer prevention and control goals set by the United Nations and China for 2030 are achieved.ConclusionsThe population‐level economic burden of CRC in China in 2019 seemed noteworthy, with the direct expenditure accounting for more than half. Without effectively reducing exposure to modifiable factors and expanding screening coverage, the burden would continue increasing.

show abstract

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

Cited by 7 publications

References 21 publications

Benefícios acidentários e previdenciários concedidos a portadores de câncer no Brasil, 2008-2014

Benefícios acidentários e previdenciários concedidos a portadores de câncer no Brasil, 2008-2014

Accident and social security benefits granted to cancer patients in Brazil, 2008-2014

Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis

Contact Info

Product

Resources

About